首页 > 市场调查报告书 > 医疗设备

心血管设备

市场调查报告书

商品编码

1633559

心律调节器市场规模、份额和成长分析（按类型、技术、植入、应用、最终用户和地区）- 产业预测，2025-2032 年

Pacemakers Market Size, Share, Growth Analysis, By Type, By Technology, By Implantability, By Application, By End User, By Region - Industry Forecast 2025-2032

出版日期: 2025年01月11日 | 出版商:

SkyQuest | 英文 224 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2023 年全球心律调节器市场规模价值 46.7 亿美元，预计将从 2024 年的 48.4 亿美元成长到 2032 年的 64.2 亿美元，预测期内（2025-2032 年）的复合年增长率为 3.6%。

心血管设备市场正在经历显着成长，这得益于心血管疾病盛行率和相关管理成本的上升、政府的支持政策以及无导线和 MRI 安全型号等先进的心律调节器技术。心臟疾病仍是全球最大的死亡原因，预计到2030年心血管疾病的经济负担将超过1.44兆美元，对心臟起搏装置的需求十分迫切。 COVID-19 大流行进一步强调了改善患者治疗效果的必要性，因为许多感染者将出现心血管併发症。国家医疗服务体系 (NHS) 和医疗保险 (Medicare) 等优惠的报销制度有利于促进市场准入。包括波士顿科学公司和美Medtronic在内的行业领导者已经推出了创新心律调节器，这些起搏器透过远端监控系统等进步提供了更高的准确性、更好的患者控制，并得到了报销计划的支持。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲国家
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前 5 家公司对比
主要企业市场定位（2024年）
主要市场参与者所采用的策略
近期市场趋势
公司市场占有率分析（2024 年）
主要企业简介
- 公司简介
- 产品系列分析
- 按细分市场分析市场份额
- 收益与前一年同期比较（2022-2024 年）

主要企业简介

Medtronic（Ireland）
Abbott Laboratories（USA）
Boston Scientific Corporation（USA）
Biotronik SE & Co. KG（Germany）
MicroPort Scientific Corporation（China）
LivaNova PLC（UK）
Lepu Medical Technology Co., Ltd.（China）
Osypka AG（Germany）
Oscor Inc.（USA）
Pacetronix（India）
Medico SpA（Italy）
Shree Pacetronix Ltd.（India）
Cordis, a Cardinal Health company（USA）
BIOTRONIK（Germany）
ELA Medical（France）
Vitatron（Netherlands）
Guidant Corporation（USA）
Intermedics Inc.（USA）

结论和建议

简介目录

Product Code: SQMIG35A2628

Global Pacemakers Market size was valued at USD 4.67 billion in 2023 and is poised to grow from USD 4.84 billion in 2024 to USD 6.42 billion by 2032, growing at a CAGR of 3.6% during the forecast period (2025-2032).

The cardiovascular device market is experiencing significant growth, driven by rising CVD prevalence and related management costs, supportive government policies, and advanced pacemaker technologies like leadless and MRI-safe models. As coronary heart disease remains a leading cause of global mortality, the financial burden of cardiovascular diseases is projected to surpass USD 1,044 billion by 2030, creating a pressing demand for cardiac pacing devices. The COVID-19 pandemic has further intensified the need for improved patient outcomes as many infected individuals also experience CVD complications. Favorable reimbursement structures like the NHS and Medicare boost market accessibility. Industry leaders, including Boston Scientific and Medtronic, are launching innovative pacemakers supported by reimbursement plans, enhancing precision and patient management through advancements like remote monitoring systems.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pacemakers market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pacemakers Market Segmental Analysis

Global Pacemakers Market is segmented by Type, Technology, Implantability, Application, End User and region. Based on Type, the market is segmented into MRI Compatible Pacemaker and Conventional Pacemaker. Based on Technology, the market is segmented into Single-chamber Pacemaker, Dual-chamber Pacemaker and Biventricular/CRT Pacemaker. Based on Implantability, the market is segmented into Implantable Pacemaker and External Pacemaker. Based on Application, the market is segmented into Bradycardia, Acute Myocardial Infarction, Arrhythmias, Atrial Fibrillation, Heart Block, Long QT Syndrome, Non-Congestive Heart Failure and Others. Based on End User, the market is segmented into Hospital, Cardiac Clinics, Ambulatory Surgical Centers (ASCs) and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pacemakers Market

The global pacemakers market is significantly driven by the rising aging population, which contributes to a heightened prevalence of age-related cardiovascular conditions. As individuals grow older, they become more susceptible to various heart rhythm disorders, resulting in a greater need for pacemaker devices. This demographic shift not only amplifies the demand for innovative cardiac solutions but also propels advancements in pacemaker technology. Consequently, healthcare providers are increasingly focused on addressing the specific needs of elderly patients, which further fuels the expansion of the pacemakers market worldwide. Thus, the intersection of aging demographics and cardiovascular health creates a substantial growth opportunity in this sector.

Restraints in the Global Pacemakers Market

Restraints in the global pacemakers market are predominantly influenced by the high costs associated with these devices. The overall expenses encompass not only the price of the pacemaker itself but also the surgical procedures required for implantation and the subsequent follow-up care. Such financial burdens can restrict accessibility, particularly in developing regions where healthcare budgets are limited. This affordability challenge can significantly impede the growth of the pacemakers market, as potential patients may be unable to obtain the necessary treatments and medical interventions, ultimately affecting market expansion and the potential reach of pacemaker technologies.

Market Trends of the Global Pacemakers Market

The Global Pacemakers market is experiencing a significant trend driven by ongoing technological advancements that enhance device functionality and patient care. Manufacturers are increasingly integrating features such as remote monitoring, which allows healthcare providers to track patient data in real-time, alongside wireless connectivity that streamlines communication. Additionally, the introduction of MRI-compatible pacemakers and innovations aimed at extending battery life further bolster market appeal. These advancements not only improve device performance but also elevate patient convenience and safety, fueling market growth as healthcare systems seek devices that meet evolving clinical needs and improve outcomes for patients with cardiac conditions.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement

Global Pacemakers Market Size by Type & CAGR (2025-2032)

Market Overview
MRI Compatible Pacemaker
Conventional Pacemaker

Global Pacemakers Market Size by Technology & CAGR (2025-2032)

Market Overview
Single-chamber Pacemaker
Dual-chamber Pacemaker
Biventricular/CRT Pacemaker

Global Pacemakers Market Size by Implantability & CAGR (2025-2032)

Market Overview
Implantable Pacemaker
- Conventional
- Leadless
External Pacemaker

Global Pacemakers Market Size by Application & CAGR (2025-2032)

Market Overview
Bradycardia
Acute Myocardial Infarction
Arrhythmias
Atrial Fibrillation
Heart Block
Long QT Syndrome
Non-Congestive Heart Failure
Others

Global Pacemakers Market Size by End User & CAGR (2025-2032)

Market Overview
Hospital
Cardiac Clinics
Ambulatory Surgical Centers (ASCs)
Others

Global Pacemakers Market Size & CAGR (2025-2032)

North America (Type, Technology, Implantability, Application, End User)
- US
- Canada
Europe (Type, Technology, Implantability, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Technology, Implantability, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Technology, Implantability, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Technology, Implantability, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biotronik SE & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Scientific Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lepu Medical Technology Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Osypka AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oscor Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pacetronix (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medico S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shree Pacetronix Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cordis, a Cardinal Health company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BIOTRONIK (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ELA Medical (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vitatron (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Guidant Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Intermedics Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments